US Starts Clinical Trial of Remdesivir as Possible Coronavirus Treatment

Military officers wearing face masks stand outside Duomo cathedral, closed by authorities due to a coronavirus outbreak, in Milan, Italy, on Feb. 24, 2020. Flavio Lo Scalzo/Reuters

Researchers in the United States started a clinical trial of the Gilead Sciences drug remdesivir to evaluate it as a possible treatment for the disease caused by the new coronavirus.

The randomized, controlled trial is meant to evaluate the safety and efficacy of the drug in adults diagnosed with the respiratory disease COVID-19.